PL2121593T3 - Przezskórne systemy dostarczania antybiotyków beta-laktamowych - Google Patents
Przezskórne systemy dostarczania antybiotyków beta-laktamowychInfo
- Publication number
- PL2121593T3 PL2121593T3 PL06832186T PL06832186T PL2121593T3 PL 2121593 T3 PL2121593 T3 PL 2121593T3 PL 06832186 T PL06832186 T PL 06832186T PL 06832186 T PL06832186 T PL 06832186T PL 2121593 T3 PL2121593 T3 PL 2121593T3
- Authority
- PL
- Poland
- Prior art keywords
- beta
- delivery systems
- transdermal delivery
- lactam antibiotics
- lactam
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2006/054724 WO2008072032A1 (en) | 2006-12-10 | 2006-12-10 | Transdermal delivery systems of beta-lactam antibiotics |
EP06832186.8A EP2121593B1 (en) | 2006-12-10 | 2006-12-10 | Transdermal delivery systems of beta-lactam antibiotics |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2121593T3 true PL2121593T3 (pl) | 2015-11-30 |
Family
ID=39511305
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06832186T PL2121593T3 (pl) | 2006-12-10 | 2006-12-10 | Przezskórne systemy dostarczania antybiotyków beta-laktamowych |
PL13161970T PL2656879T3 (pl) | 2006-12-10 | 2006-12-10 | Przezskórne układy podania antybiotyków beta-laktamowych |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13161970T PL2656879T3 (pl) | 2006-12-10 | 2006-12-10 | Przezskórne układy podania antybiotyków beta-laktamowych |
Country Status (8)
Country | Link |
---|---|
US (3) | US20100040548A1 (pl) |
EP (3) | EP2656879B1 (pl) |
JP (1) | JP5324463B2 (pl) |
CN (1) | CN101547898B (pl) |
CA (1) | CA2671938C (pl) |
ES (2) | ES2633020T3 (pl) |
PL (2) | PL2121593T3 (pl) |
WO (1) | WO2008072032A1 (pl) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090238763A1 (en) | 2006-07-09 | 2009-09-24 | Chongxi Yu | High penetration compositions and uses thereof |
US20090221703A1 (en) | 2006-07-09 | 2009-09-03 | Chongxi Yu | High penetration composition and uses thereof |
CN101541743A (zh) | 2006-11-08 | 2009-09-23 | 于崇曦 | 多肽及相关化合物的透皮给药系统 |
EP2656879B1 (en) | 2006-12-10 | 2017-06-28 | Chongxi Yu | Transdermal delivery systems of beta-lactam antibiotics |
JP5389668B2 (ja) | 2007-01-31 | 2014-01-15 | チョンシー ユー | 皮膚浸透率の非常に高い1H−イミダゾ[4,5−c]キノリン−4−アミン及び関連化合物の正に荷電した水溶性プロドラッグ |
KR20190091378A (ko) | 2007-06-04 | 2019-08-05 | 테크필즈 인크 | 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(nsaia) 약물전구체 및 이들의 새로운 의약적 용도 |
EP2313064A2 (en) * | 2008-07-15 | 2011-04-27 | BASF Catalysts LLC | Methods, systems and devices for administration of chlorine dioxide |
KR20210123406A (ko) | 2008-12-04 | 2021-10-13 | 충시 위 | 고투과력을 가진 조성물 및 이의 적용 |
US20100196512A1 (en) * | 2009-02-04 | 2010-08-05 | Basf Catalyst Llc | Treatment of Non-Oral Biological Tissue with Chlorine Dioxide |
PL2427475T3 (pl) | 2009-05-08 | 2021-07-19 | Techfields Biochem Co., Ltd. | Kompozycje proleku o wysokim przenikaniu peptydów i związków powiązanych z peptydami |
US9969751B2 (en) | 2009-06-10 | 2018-05-15 | Techfields Pharma Co., Ltd. | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds |
EP2440523A4 (en) * | 2009-06-10 | 2014-03-19 | Chongxi Yu | COMPOSITION WITH STRONG PENETRATION OR PRODRUGS FROM ANTIMICROBIA AND COMPOUNDS IN ANTIMICROBIA |
CN102803211B (zh) * | 2009-06-10 | 2016-01-27 | 上海泰飞尔生化技术有限公司 | 具有高穿透性的抗微生物剂和抗微生物剂相关化合物的前药组合物 |
TWI496577B (zh) * | 2010-06-10 | 2015-08-21 | Shanghai Techfields Biochem Co Ltd | 抗菌劑和抗菌劑相關化合物的高滲透性前藥組合物 |
AP2013007268A0 (en) * | 2011-05-02 | 2013-11-30 | Aptalis Pharmatech Inc | Rapid dissolve tablet compositions for vaginal administration |
KR102443057B1 (ko) | 2012-01-18 | 2022-09-14 | 테크필즈 파마 코., 엘티디. | 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물 |
US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
JP5795343B2 (ja) * | 2013-01-23 | 2015-10-14 | チョンシー ユー | β−ラクタム抗生物質の経皮送達システム |
US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
KR102329764B1 (ko) | 2013-03-15 | 2021-11-23 | 머크 샤프 앤드 돔 코포레이션 | 세프톨로잔 항균성 조성물 |
US20140274991A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane pharmaceutical compositions |
EP3043797B1 (en) | 2013-09-09 | 2020-04-08 | Merck Sharp & Dohme Corp. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
US20150094293A1 (en) | 2013-09-27 | 2015-04-02 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
CN103539802B (zh) * | 2013-10-15 | 2016-04-27 | 湖北美天生物科技有限公司 | 一种喷沙西林氢碘酸盐的合成方法 |
WO2018090004A2 (en) * | 2016-11-14 | 2018-05-17 | The University Of North Carolina At Chapel Hill | Tuberculosis therapeutic compounds and methods |
US11613517B2 (en) | 2018-03-02 | 2023-03-28 | Oregon Health & Science University | Amide prodrugs of small molecule nuclear receptor modulators |
US11827596B2 (en) | 2018-12-12 | 2023-11-28 | Autobahn Therapeutics, Inc. | Thyromimetics |
EP3931180A1 (en) | 2019-03-01 | 2022-01-05 | Autobahn Therapeutics, Inc. | Novel thyromimetics |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2694063A (en) * | 1949-07-07 | 1954-11-09 | Leo Pharm Prod Ltd | Quaternary ammonium addition salts of penicillin esters |
US2694031A (en) * | 1949-07-07 | 1954-11-09 | Leo Pharm Prod Ltd | Hydroiodides of amino esters of penicillin and oil composition thereof |
DE858699C (de) * | 1949-07-07 | 1952-12-08 | Leo Pharm Prod Ltd | Verfahren zur Herstellung von Estern des Penicillins mit substituierten Aminoalkoholen bzw. deren Salzen oder quaternaeren Ammoniumverbindungen |
US2694061A (en) * | 1949-07-07 | 1954-11-09 | Leo Pharm Prod Ltd | Method of producing aminoalcohol esters of penicillin |
US2593852A (en) | 1949-11-16 | 1952-04-22 | Bristol Lab Inc | Penicillin amides |
GB759603A (en) | 1952-07-10 | 1956-10-24 | Yvan Villax | Method for the production of esters of penicillin |
GB768347A (en) * | 1953-02-06 | 1957-02-13 | Knud Abildgaard | Sulphanilate salts of amino alcohol esters of penicillin |
US3957764A (en) * | 1969-11-11 | 1976-05-18 | Lovens Kemiske Fabrik Produktionsaktieselskab | 6-aminopenicillanic acid derivatives |
CA996929A (en) * | 1971-04-05 | 1976-09-14 | Kohzi Nakano | Acyloxyalkyl ester derivatives of penicillin |
GB1335317A (en) | 1971-06-23 | 1973-10-24 | Leo Pharm Prod Ltd | Cephalosporin esters salts thereof and methods for their pre paration |
ES409580A1 (es) * | 1972-12-13 | 1975-12-01 | Andreu Sa Dr | Procedimiento para la obtencion de esteres alquilaminoal- quilicos de la alfa-aminobencilpenicilina. |
GB1482910A (en) | 1973-11-23 | 1977-08-17 | Mercer Ltd F B | Commodity packaging |
IT1048274B (it) | 1974-03-02 | 1980-11-20 | Farmaceutici Italia | Esteri di penicilline e di cefauosporine |
ES428213A1 (es) * | 1974-07-12 | 1976-07-16 | Andreu Sa Dr | Procedimiento para la obtencion de esteres dialquilaminoal-quilicos de penicilina. |
US4150157A (en) | 1976-06-11 | 1979-04-17 | Beecham Group Limited | Penicillin compositions |
GB1569421A (en) * | 1976-06-11 | 1980-06-18 | Beecham Group Ltd | Penicillin compositions |
GB1578730A (en) | 1976-06-24 | 1980-11-05 | Beecham Group Ltd | Esters of penicillin antibiotics |
US4215120A (en) | 1977-07-14 | 1980-07-29 | Beecham Group Limited | Penicillin esters and their preparation |
IL58939A (en) | 1978-12-18 | 1983-03-31 | Meiji Seika Kaisha | 7 alpha-methoxycephalosporin derivatives and their production |
US4311706A (en) | 1980-01-22 | 1982-01-19 | Interx Research Corporation | Novel dopa/dopamine prodrugs |
JPS5852291A (ja) | 1981-09-22 | 1983-03-28 | Kureha Chem Ind Co Ltd | ペニシリン系抗生物質誘導体とその医薬剤 |
JPS58126846A (ja) * | 1982-01-22 | 1983-07-28 | Kaken Pharmaceut Co Ltd | プロピオン酸アミノアルキルエステル誘導体、その製法およびそれを有効成分とする消炎、鎮痛剤 |
US4428935A (en) | 1982-05-24 | 1984-01-31 | Pfizer Inc. | Penicillanic acid dioxide prodrug |
JPS59128392A (ja) | 1982-12-29 | 1984-07-24 | Kureha Chem Ind Co Ltd | セフアロスポリン誘導体及び該誘導体を含有する薬剤 |
FR2542998B1 (fr) | 1983-03-24 | 1986-01-31 | Rhone Poulenc Sante | Nouvelle forme transdermale du dinitrate d'isosorbide |
DE3347128A1 (de) | 1983-12-22 | 1985-07-11 | Schering AG, 1000 Berlin und 4709 Bergkamen | 9-halogen-(delta)(pfeil hoch)2(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
GB2157284B (en) * | 1984-04-11 | 1987-11-04 | Leo Pharm Prod Ltd | 6-b-halopenicillanic acid salts |
EP0262744B1 (en) | 1986-10-02 | 1994-03-23 | Asahi Kasei Kogyo Kabushiki Kaisha | A process for preparing 3-alkoxymethylcephalosphorins |
JPH01131181A (ja) * | 1986-10-02 | 1989-05-24 | Asahi Chem Ind Co Ltd | 3−アルコキシメチルセファロスポリン類の製造方法 |
US5321020A (en) * | 1989-03-28 | 1994-06-14 | Pfizer Inc. | Antibacterial 2-carbapenem derivatives |
JP2672363B2 (ja) | 1989-03-29 | 1997-11-05 | 帝人株式会社 | 有機非線形光学材料 |
AU675211B2 (en) | 1991-10-16 | 1997-01-30 | Richardson-Vicks Inc. | Enhanced skin penetration system for improved topical delivery of drugs |
US5629019A (en) * | 1992-02-27 | 1997-05-13 | Alza Corporation | Formulations with hydrophobic permeation enhancers |
NZ332719A (en) | 1996-05-10 | 2000-01-28 | Upjohn Co | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
US5929086A (en) | 1996-05-10 | 1999-07-27 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
US6011049A (en) | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
SE9900941D0 (sv) | 1998-12-23 | 1999-03-16 | Nomet Management Serv Bv | Novel retinoic acid derivatives and their use |
WO2000067754A1 (en) | 1999-05-12 | 2000-11-16 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
US6908900B2 (en) | 2001-01-17 | 2005-06-21 | Zimmer & Associates Ag | Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients |
WO2003022270A1 (en) | 2001-09-13 | 2003-03-20 | Noven Pharmaceuticals, Inc. | Transdermal administration of an enalapril ester |
AU2002347747A1 (en) | 2002-07-23 | 2004-02-09 | Ardenia Investments Ltd. | Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents |
NZ542671A (en) | 2003-03-12 | 2008-12-24 | Celgene Corp | 7-Amido-isoindolyl compounds and their pharmaceutical uses |
US7052715B2 (en) | 2003-04-11 | 2006-05-30 | All Natural Fmg, Inc. | Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof |
DE102004025324A1 (de) | 2004-05-19 | 2005-12-08 | Boehringer Ingelheim Vetmedica Gmbh | Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung |
US7074775B2 (en) | 2004-09-14 | 2006-07-11 | Miller Landon C G | Aminobutyramide conjugate and a pharmaceutical composition for treatment of neuronal disorders |
US20060222692A1 (en) * | 2005-03-31 | 2006-10-05 | Fairfield Clinical Trials Llc | Method and compositions for transdermal administration of antimicrobial medications |
KR101446813B1 (ko) | 2006-04-06 | 2014-10-01 | 뉴파쎄 인크. | 도파민 연관된 상태의 치료를 위한 이식체 |
WO2008007171A1 (en) | 2006-07-09 | 2008-01-17 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of aspirin |
WO2008012602A1 (en) | 2006-07-25 | 2008-01-31 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of diclofenac with very fast skin penetration rate |
CN101489985B (zh) | 2006-07-18 | 2014-01-08 | 天津昕晨泰飞尔医药科技有限公司 | 具有快速皮肤穿透率的带正电荷的水溶性布洛芬前药 |
CN101500983B (zh) | 2006-07-26 | 2015-09-16 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性二氟尼柳及相关化合物的前药 |
DK2049482T3 (en) | 2006-08-08 | 2016-02-01 | Techfields Biochem Co Ltd | Positively charged, water-soluble prodrugs of aryl and heteroaryl acetic acids with very fast skin penetration rate |
US8458932B2 (en) | 2006-08-11 | 2013-06-11 | Alameda Technology, Llc | Optical illusion device |
CN101506161B (zh) | 2006-08-15 | 2013-11-13 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性的芳基和杂芳基丙酸类前药 |
WO2008026776A1 (fr) | 2006-08-31 | 2008-03-06 | Nanocarrier Co., Ltd. | Composition transdermique, composition pharmaceutique transdermique et composition cosmétique transdermique comprenant un ingrédient actif encapsulant une micelle polymère |
CN101506143B (zh) | 2006-09-03 | 2013-06-05 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性的对乙酰氨基酚及其相关化合物的前药 |
EP2623495B1 (en) | 2006-09-03 | 2019-05-01 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate |
EP2084165B1 (en) | 2006-10-11 | 2013-06-12 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate |
CN101541743A (zh) | 2006-11-08 | 2009-09-23 | 于崇曦 | 多肽及相关化合物的透皮给药系统 |
EP2656879B1 (en) * | 2006-12-10 | 2017-06-28 | Chongxi Yu | Transdermal delivery systems of beta-lactam antibiotics |
JP5389668B2 (ja) | 2007-01-31 | 2014-01-15 | チョンシー ユー | 皮膚浸透率の非常に高い1H−イミダゾ[4,5−c]キノリン−4−アミン及び関連化合物の正に荷電した水溶性プロドラッグ |
KR20190091378A (ko) | 2007-06-04 | 2019-08-05 | 테크필즈 인크 | 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(nsaia) 약물전구체 및 이들의 새로운 의약적 용도 |
US9969751B2 (en) * | 2009-06-10 | 2018-05-15 | Techfields Pharma Co., Ltd. | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds |
-
2006
- 2006-12-10 EP EP13161970.2A patent/EP2656879B1/en active Active
- 2006-12-10 CA CA2671938A patent/CA2671938C/en active Active
- 2006-12-10 WO PCT/IB2006/054724 patent/WO2008072032A1/en active Application Filing
- 2006-12-10 EP EP06832186.8A patent/EP2121593B1/en not_active Not-in-force
- 2006-12-10 ES ES13161970.2T patent/ES2633020T3/es active Active
- 2006-12-10 ES ES06832186.8T patent/ES2547258T3/es active Active
- 2006-12-10 PL PL06832186T patent/PL2121593T3/pl unknown
- 2006-12-10 CN CN200680056580.XA patent/CN101547898B/zh active Active
- 2006-12-10 PL PL13161970T patent/PL2656879T3/pl unknown
- 2006-12-10 JP JP2009540881A patent/JP5324463B2/ja not_active Expired - Fee Related
- 2006-12-10 EP EP17177947.3A patent/EP3357926A1/en not_active Withdrawn
-
2009
- 2009-06-10 US US12/482,373 patent/US20100040548A1/en not_active Abandoned
-
2012
- 2012-07-16 US US13/550,361 patent/US10233197B2/en not_active Expired - Fee Related
-
2019
- 2019-02-06 US US16/268,637 patent/US20210206782A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP3357926A1 (en) | 2018-08-08 |
PL2656879T3 (pl) | 2017-09-29 |
CN101547898B (zh) | 2014-09-24 |
JP5324463B2 (ja) | 2013-10-23 |
US20130018029A1 (en) | 2013-01-17 |
EP2656879B1 (en) | 2017-06-28 |
ES2633020T3 (es) | 2017-09-18 |
CA2671938A1 (en) | 2008-06-19 |
CA2671938C (en) | 2017-10-17 |
EP2656879A1 (en) | 2013-10-30 |
EP2121593A1 (en) | 2009-11-25 |
WO2008072032A1 (en) | 2008-06-19 |
ES2547258T3 (es) | 2015-10-02 |
EP2121593A4 (en) | 2010-09-08 |
US20210206782A1 (en) | 2021-07-08 |
JP2010512380A (ja) | 2010-04-22 |
US10233197B2 (en) | 2019-03-19 |
US20100040548A1 (en) | 2010-02-18 |
EP2121593B1 (en) | 2015-06-17 |
CN101547898A (zh) | 2009-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2121593A4 (en) | TRANSDERMAL ADMINISTRATION SYSTEMS FOR BETA-LACTAM ANTIBIOTICS | |
HK1221477A1 (zh) | 多肽及相關化合物的透皮給藥系統 | |
IL200077A0 (en) | Transdermal delivery systems | |
EP2101745A4 (en) | DISTRIBUTION OF MEDICINAL PRODUCTS | |
HK1203867A1 (en) | Transdermal methods and systems for the delivery of anti-migraine compounds | |
GB2444395B (en) | Delivery devices | |
GB2444394B (en) | Delivery devices | |
IL206184A0 (en) | Systems and methods for delivery of materials | |
IL198893A0 (en) | Lipase variants for pharmaceutical use | |
IL198927A0 (en) | Imidazopyridine inhibitors of iap | |
GB0910952D0 (en) | Ad delivery and implementation system | |
EP2164328B8 (en) | Therapeutic pyrazoloquinoline urea derivatives | |
EP2070919A4 (en) | SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION | |
ZA201000215B (en) | Sequential enzyme delivery system | |
GB0617222D0 (en) | Antibiotics | |
SI2084270T1 (sl) | Izdelava beta - laktam antibiotikov | |
EP2114404A4 (en) | COMPOUND AND PHARMACEUTICAL COMPOSITION | |
HK1202068A1 (en) | Transdermal delivery systems of beta lactam antibiotics | |
GB2476731B (en) | Delivery devices | |
EP1993591A4 (en) | TARGETED RELEASE OF PHARMACEUTICAL COMPOUNDS | |
AU2006905107A0 (en) | Transdermal delivery of anti-inflammatory agents | |
GB2461433B (en) | Delivery devices | |
AU2007903316A0 (en) | Transdermal delivery of active agents | |
GB0608210D0 (en) | Methods And Devices For Targeted Drug Deposition | |
AU2006906550A0 (en) | Heparanase Inhibitors |